Business Context and Reporting Period
This Form 8-K Current Report was filed by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) on March 13, 2008. The filing reports corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial performance data.
Material Changes
The Board of Directors appointed two new non-employee directors, increasing the Board size to eight members:
- Robert A. Hagemann
- Cecil B. Pickett, Ph.D.
Both directors were appointed with terms expiring at the 2008 annual meeting of stockholders scheduled for May 5, 2008. Neither director was immediately assigned to Board committees, though future appointments are expected.
Guidance, Outlook, and Compensation
There is no financial guidance or outlook provided in this filing. Regarding compensation, the new directors will participate in the standard non-employee director compensation arrangements described in the Company's preliminary proxy statement filed on March 3, 2008. They are also expected to execute the Company's standard form of non-employee director indemnification agreement.
Investor Verification Checklist
- Verify the biographical details and qualifications of Robert A. Hagemann and Cecil B. Pickett, Ph.D.
- Review the preliminary proxy statement filed on March 3, 2008, for details on non-employee director compensation.
- Confirm the date of the 2008 annual meeting of stockholders (May 5, 2008) for the ratification of these appointments.
- Check for future 8-K filings regarding the specific committee assignments for the new directors.